Holdings in Company
21 4월 2007 - 12:26AM
UK Regulatory
RNS Number:2746V
Biocare Solutions PLC
20 April 2007
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
Biocare Solutions Plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: (No)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (No)
An event changing the breakdown of voting rights: (Yes)
Other (please specify) : (N/A)
3. Full name of person(s) subject to the notification obligation (iii):
Fidelity International Limited (FIL)
4. Full name of shareholder(s) (if different from 3.) (iv):
See Section 9
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
Revised due to DTR rules
6. Date on which issuer notified:
1 March 2007
7. Threshold(s) that is/are crossed or reached:
-
8. Notified details:
-
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the
using the ISIN CODE Triggering transaction (vi)
Number of Number of voting
shares Rights (viii)
ISIN 250,995 250,995
GB00B1528F83
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
250,995 0.27%
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting % of voting
rights rights
250,995 0.27%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
FIL
Issuer name: BIOCARE SOLUTIONS
-------------------
Current ownership 0.27%
percentage:
Total shares held: 250,995
Issued share capital: 91,654,812
SHARES HELD NOMINEE MANAGEMENT
---------------- ------------- ---------------- COMPANY
-------------
250,995 BROWN BROS HARRIMN LTD FIL
LUX
Proxy Voting:
10. Name of the proxy holder:
FMR Corp
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
As discussed with the FSA, prior to the implementation of the EU Transparency
Directive, we aggregated the interests in shares of FMR Corp (FMR) and Fidelity
International Limited (FIL) together for the purposes of shareholder reporting.
According to the new DTR rules we are now reporting the indirect holdings of FMR
and FIL separately. A separate notification is being submitted for FIL. Please
note these holdings are correct as of close of business 27 February 2007.
14. Contact name:
Laura Cotterell
15. Contact telephone number:
01737 837148
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
FMR Corp
Contact address (registered office for legal entities):
82 Devonshire Street, Boston, MA,
02109 USA
Phone number:
01737 837148
Other useful information (at least legal representative for legal persons):
Company Secretary
B: Identity of the notifier, if applicable (xvii)
Full name:
Fidelity Investments
Contact address:
Windmill Court XTW2B, Millfield Lane,
Lower Kingswood, Tadworth, Surrey
KT20 6RB
Phone number:
01737 837148
Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):
Authorised to make this filing under power of attorney
C: Additional information :
As discussed with the FSA, prior to the implementation of the EU Transparency
Directive, we aggregated the interests in shares of FMR Corp (FMR) and Fidelity
International Limited (FIL) together for the purposes of shareholder reporting.
According to the new DTR rules we are now reporting the indirect holdings of FMR
and FIL separately. A separete notification is being submitted for FIL, Please
note these holdings are correct as of close of business 27 February 2007.
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
Biocare Solutions Plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: (No)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (No)
An event changing the breakdown of voting rights: (Yes)
Other (please specify) : (N/A)
3. Full name of person(s) subject to the notification obligation (iii):
FMR Corp
4. Full name of shareholder(s) (if different from 3.) (iv):
See Section 9
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
Revised due to DTR rules
6. Date on which issuer notified:
1 March 2007
7. Threshold(s) that is/are crossed or reached:
-
8. Notified details:
-
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the
using the ISIN CODE Triggering transaction (vi)
Number of Number of voting
shares Rights (viii)
ISIN 4,899,670 4,899,670
GB00B1528F83
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
4,899,670 5.35%
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting % of voting
rights rights
4,899,670 5.35%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
FIL
Issuer name: BIOCARE SOLUTIONS
-------------------
Current ownership 5.35%
percentage:
Total shares held: 4,899,670
Issued share capital: 91,654,812
SHARES HELD NOMINEE MANAGEMENT
---------------- ------------- ---------------- COMPANY
-------------
4,899,670 MELLON BANK N.A. FMRCO
Proxy Voting:
10. Name of the proxy holder:
Fidelity International Limited (FIL)
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
As discussed with the FSA, prior to the implementation of the EU Transparency
Directive, we aggregated the interests in shares of FMR Corp (FMR) and Fidelity
International Limited (FIL) together for the purposes of shareholder reporting.
According to the new DTR rules we are now reporting the indirect holdings of FMR
and FIL separately. A separate notification is being submitted for FMR Corp.
Please note these holdings are correct as of close of business 27 February 2007.
14. Contact name:
Laura Cotterell
15. Contact telephone number:
01737 837148
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
Fidelity International Limited (FIL)
Contact address (registered office for legal entities):
Pembroke Hall, 42 Crow Lane,
Pembroke, HM19 Bermuda
Phone number:
01737 837148
Other useful information (at least legal representative for legal persons):
Company Secretary
B: Identity of the notifier, if applicable (xvii)
Full name:
Fidelity Investments International
Contact address:
Windmill Court XTW2B, Millfield Lane,
Lower Kingswood, Tadworth, Surrey
KT20 6RB
Phone number:
01737 837148
Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):
Authorised to make this filing under power of attorney
C: Additional information :
As discussed with the FSA, prior to the implementation of the EU Transparency
Directive, we aggregated the interests in shares of FMR Corp (FMR) and Fidelity
International Limited (FIL) together for the purposes of shareholder reporting.
According to the new DTR rules we are now reporting the indirect holdings of FMR
and FIL separately. A separete notification is being submitted for FMR Corp.
Please note these holdings are correct as of close of business 27 February 2007.
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
Biocare Solutions Plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: (No)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (No)
An event changing the breakdown of voting rights: (No)
Other (please specify) : (Yes) New Exemption Trading Book (DTR 5.1.3 4))
3. Full name of person(s) subject to the notification obligation (iii):
Moore Credit Fund, Ltd
4. Full name of shareholder(s) (if different from 3.) (iv):
N/A
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
N/A
6. Date on which issuer notified:
19 March 2007
7. Threshold(s) that is/are crossed or reached:
Re-notification due to new reporting requirements
8. Notified details:
Holdings at 5.46%
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the
using the ISIN CODE Triggering transaction (vi)
Number of Number of voting
shares Rights (viii)
GB00B1528F83 5,000,000 5.46%
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting % of voting
rights rights
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
N/A
Proxy Voting:
10. Name of the proxy holder:
Institutional Shareholder Services (ISS)
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
-
14. Contact name:
Julie O'Neil
15. Contact telephone number:
020 7470 7570
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which
voting rights are attached (ii):
Biocare Solutions Plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: (No)
An acquisition or disposal of financial instruments which may result in the
acquisition of shares already issued to which voting rights are attached: (No)
An event changing the breakdown of voting rights: (No)
Other (please specify) : (Yes) Statutory notification for holding above 3%
3. Full name of person(s) subject to the notification obligation (iii):
RAB Special Situations (Master) Fund LTD
4. Full name of shareholder(s) (if different from 3.) (iv):
Credit Suisse Client Nominees (UK) Limited
5. Date of the transaction (and date on which the threshold is crossed or
reached if different) (v):
N/A
6. Date on which issuer notified:
20/03/07 (holding as at 16/03/07)
7. Threshold(s) that is/are crossed or reached:
Above 3%
8. Notified details:
N/A
A: Voting rights attached to shares
Class/type of shares if possible Situation previous to the
using the ISIN CODE Triggering transaction (vi)
Number of Number of voting
shares Rights (viii)
Ordinary shares 35040000 38.23%
Resulting situation after the triggering transaction (vii)
Class/type of shares Number of shares Number of voting rights % of voting rights
if possible using (ix)
the ISIN CODE
Direct Direct (x) Indirect (xi) Direct Indirect
38.23% 38.23%
B: Financial Instruments
Resulting situation after the triggering transaction (xii)
Type of Expiration Date Exercise/Conversion Number of voting % of voting
financial (xiii) Period/ Date (xiv) rights that may be rights
instrument acquired if the
instrument is
exercised/
converted.
Total (A+B)
Number of voting % of voting
rights rights
A Only 38.23%
9. Chain of controlled undertakings through which the voting rights and/or the
financial instruments are effectively held, if applicable (xv):
RAB Capital plc acts as investment manager for RAB Special Situations (Master)
Fund Ltd. RAB Capital plc does not act as custodian for its clients and
therefore the shares are held in the nominee name of the custodian of its
clients, which is Credit Suisse Client Nominees (UK) limited.
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
N/A
14. Contact name:
Legal Team
15. Contact telephone number:
020 7389 7000
Annex to Notification Of Major Interests In Shares (xvi)
A: Identity of the person or legal entity subject to the notification obligation
Full name (including legal form for legal entities):
RAB Capital Plc for and behalf of RAB Special Situations (Master) Fund Ltd
Contact address (registered office for legal entities):
C/O RAB Capital plc,
1 Adam Street
London WC2N 6LE
Phone number:
020 7389 7000
Other useful information (at least legal representative for legal persons):
-
B: Identity of the notifier, if applicable (xvii)
Full name:
All as above
Contact address:
-
Phone number:
-
Other useful information (e.g. functional relationship with the person or legal
entity subject to the notification obligation):
-
C: Additional information :
N/A
This information is provided by RNS
The company news service from the London Stock Exchange
END
HOLBUGDSSDDGGRG
Biocare (LSE:BSN)
과거 데이터 주식 차트
부터 5월(5) 2024 으로 6월(6) 2024
Biocare (LSE:BSN)
과거 데이터 주식 차트
부터 6월(6) 2023 으로 6월(6) 2024
